JP2007531731A5 - - Google Patents

Download PDF

Info

Publication number
JP2007531731A5
JP2007531731A5 JP2007506319A JP2007506319A JP2007531731A5 JP 2007531731 A5 JP2007531731 A5 JP 2007531731A5 JP 2007506319 A JP2007506319 A JP 2007506319A JP 2007506319 A JP2007506319 A JP 2007506319A JP 2007531731 A5 JP2007531731 A5 JP 2007531731A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
formula
independently
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007506319A
Other languages
English (en)
Japanese (ja)
Other versions
JP4991037B2 (ja
JP2007531731A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/011124 external-priority patent/WO2005094897A2/en
Publication of JP2007531731A publication Critical patent/JP2007531731A/ja
Publication of JP2007531731A5 publication Critical patent/JP2007531731A5/ja
Application granted granted Critical
Publication of JP4991037B2 publication Critical patent/JP4991037B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007506319A 2004-04-01 2005-03-31 イオンチャネル調節化合物を含む薬物結合体 Expired - Fee Related JP4991037B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US55940504P 2004-04-01 2004-04-01
US58699204P 2004-07-08 2004-07-08
US60/586,992 2004-07-08
PCT/US2005/011124 WO2005094897A2 (en) 2004-04-01 2005-03-31 Pegylated ion channel modulating compounds
US60/559,405 2005-04-01

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2008088707A Division JP2008179653A (ja) 2004-04-01 2008-03-28 Ｐｅｇ化イオンチャネル調節化合物
JP2008088708A Division JP2008214353A (ja) 2004-04-01 2008-03-28 Ｐｅｇ化イオンチャネル調節化合物

Publications (3)

Publication Number Publication Date
JP2007531731A JP2007531731A (ja) 2007-11-08
JP2007531731A5 true JP2007531731A5 (https=) 2008-05-15
JP4991037B2 JP4991037B2 (ja) 2012-08-01

Family

ID=34972985

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2007506319A Expired - Fee Related JP4991037B2 (ja) 2004-04-01 2005-03-31 イオンチャネル調節化合物を含む薬物結合体
JP2007506547A Expired - Fee Related JP4954864B2 (ja) 2004-04-01 2005-03-31 イオンチャネル調節化合物のプロドラッグおよびその使用
JP2008088708A Pending JP2008214353A (ja) 2004-04-01 2008-03-28 Ｐｅｇ化イオンチャネル調節化合物
JP2008088707A Pending JP2008179653A (ja) 2004-04-01 2008-03-28 Ｐｅｇ化イオンチャネル調節化合物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2007506547A Expired - Fee Related JP4954864B2 (ja) 2004-04-01 2005-03-31 イオンチャネル調節化合物のプロドラッグおよびその使用
JP2008088708A Pending JP2008214353A (ja) 2004-04-01 2008-03-28 Ｐｅｇ化イオンチャネル調節化合物
JP2008088707A Pending JP2008179653A (ja) 2004-04-01 2008-03-28 Ｐｅｇ化イオンチャネル調節化合物

Country Status (6)

Country Link
US (2) US7786119B2 (https=)
EP (1) EP1729814A2 (https=)
JP (4) JP4991037B2 (https=)
CA (1) CA2561733A1 (https=)
MX (1) MXPA06011420A (https=)
WO (1) WO2005094897A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090041841A1 (en) * 2003-05-02 2009-02-12 Cardiome Pharma Corp. Controlled release tablet formulations for the prevention of arrhythmias
US7705036B2 (en) * 2004-04-01 2010-04-27 Cardiome Pharma Corp. Deuterated aminocyclohexyl ether compounds and processes for preparing same
US7754897B2 (en) 2005-06-15 2010-07-13 Cardiome Pharma Corp. Synthetic processes for the preparation of aminocyclohexyl ether compounds
WO2005097087A2 (en) * 2004-04-01 2005-10-20 Cardiome Pharma Corp. Merged ion channel modulating compounds and uses thereof
MXPA06011419A (es) 2004-04-01 2007-04-20 Cardiome Pharma Corp Profarmacos de compuestos moduladores de canales ionicos y usos de los mismos.
JP4991037B2 (ja) * 2004-04-01 2012-08-01 カーディオム ファーマ コーポレイション イオンチャネル調節化合物を含む薬物結合体
EP1828099B1 (en) 2004-11-18 2020-01-22 Correvio International Sàrl Synthetic process for aminocyclohexyl ether compounds
JP2007131597A (ja) * 2005-11-11 2007-05-31 Toray Fine Chemicals Co Ltd ベンジルオキシピロリジン誘導体の製造方法
JP5004067B2 (ja) * 2005-10-31 2012-08-22 東レ・ファインケミカル株式会社 ベンジルオキシ含窒素環状化合物の製造法
JP5004073B2 (ja) * 2006-06-13 2012-08-22 東レ・ファインケミカル株式会社 光学活性ベンジルオキシピロリジン誘導体塩酸塩粉体及びその製造法
CA2627502C (en) * 2005-10-31 2014-04-01 Toray Fine Chemicals Co., Ltd. Process for production of benzyloxypyrrolidine derivative, and process for production of hydrochloride salt powder of optically active benzyloxypyrrolidine derivative
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
US8748648B2 (en) 2007-09-06 2014-06-10 Nektar Therapeutics Oligomer-calcium channel blocker conjugates
WO2009089053A1 (en) * 2008-01-11 2009-07-16 Nektar Therapeutics Al, Corporation Oligomer-guanidine class conjugates
JP5773877B2 (ja) * 2008-10-22 2015-09-02 アキュセラ インコーポレイテッド 眼の疾患及び障害を治療する化合物
US20120010144A1 (en) * 2009-04-03 2012-01-12 Ragheb Assaly Peg-albumin composition having at least one protected thiol region as a platform for medications
US8993614B2 (en) 2012-03-15 2015-03-31 F. Hoffmann-La Roche Ag Substituted pyrrolidine-2-carboxamides
US9974759B2 (en) 2013-05-31 2018-05-22 Indiana University Research And Technology Corporation Beta 2 adrenoceptor antagonists for treating orthostatic hypotension

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684728A (en) * 1979-01-12 1987-08-04 Bayer Aktiengesellschaft Solubilizing biologically active compounds with reactive hydrogen atoms
IT1145362B (it) 1980-03-06 1986-11-05 Sigma Tau Ind Farmaceuti Classe di acil-derivati della carnitina procedimento per la loro preparazione e loro uso terapeutico
US5160734A (en) * 1987-11-25 1992-11-03 American Cyanamid Company Sustained release delivery system for substituted dihydropyridine calcium channel blockers
ATE76292T1 (de) * 1987-11-25 1992-06-15 American Cyanamid Co System fuer die verzoegerte (kontrollierte) freisetzung von substituierten dihydropyridincalciumantagonisten.
US20030186869A1 (en) 1990-05-14 2003-10-02 George Poiani Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor
US6517824B1 (en) 1990-05-14 2003-02-11 University Of Medicine & Denistry Of New Jersey Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor
US5219564A (en) 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
US5244889A (en) 1991-11-26 1993-09-14 Ciba-Geigy Corporation Certain macrocyclic lactam derivatives
US6217869B1 (en) 1992-06-09 2001-04-17 Neorx Corporation Pretargeting methods and compounds
US5298492A (en) 1992-08-04 1994-03-29 Schering Corporation Diamino acid derivatives as antihypertensives
US5681811A (en) 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
US6191105B1 (en) 1993-05-10 2001-02-20 Protein Delivery, Inc. Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
JP3563738B2 (ja) 1993-06-11 2004-09-08 エーザイ株式会社 アミノ酸誘導体
DE69429524T2 (de) * 1993-09-24 2002-08-08 The University Of British Columbia, Vancouver Aminocyclohexylester und ihre anwendung
CN1087725C (zh) 1994-03-25 2002-07-17 同位素技术有限公司 用氘代方法增强药物效果
DE69735057T2 (de) * 1996-03-12 2006-08-31 PG-TXL Co., L.P., Houston Wasserlösliche paclitaxel-prodrogen
US6441025B2 (en) * 1996-03-12 2002-08-27 Pg-Txl Company, L.P. Water soluble paclitaxel derivatives
US6214966B1 (en) 1996-09-26 2001-04-10 Shearwater Corporation Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
AU5194998A (en) 1996-11-01 1998-05-29 Magainin Pharmaceuticals, Inc. Certain aminosterol compounds and uses therefor
EP0884325A1 (en) 1997-04-24 1998-12-16 Akzo Nobel N.V. Thrombin inhibitors containing a peptidyl heterocycle
US6342507B1 (en) 1997-09-05 2002-01-29 Isotechnika, Inc. Deuterated rapamycin compounds, method and uses thereof
EP0991660B8 (en) 1997-10-08 2006-04-05 Isotechnika,Inc. DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
CA2326777C (en) 1998-04-01 2011-12-20 Nortran Pharmaceuticals Inc. Aminocyclohexyl ether compounds and uses thereof
CA2319142A1 (en) 1998-06-08 1999-12-16 Advanced Medicine, Inc. Novel therapeutic agents for membrane transporters
EP1143896B1 (en) * 1998-10-20 2006-12-13 The University of North Carolina at Chapel Hill Methods of hydrating the nasal mucosal surface
WO2000047547A2 (en) * 1999-02-12 2000-08-17 Nortran Pharmaceuticals Inc. Cycloalkyl amine compounds and uses thereof
WO2000066110A1 (en) 1999-04-29 2000-11-09 Merck Patent Gmbh Glycine cleavage system inhibitors as potential antipsychotics
CA2311483A1 (en) * 2000-06-12 2001-12-12 Gregory N Beatch IMIDAZO [1,2-A] PYRIDINIC ETHERS AND USES THEREOF
WO2002028412A1 (en) 2000-10-05 2002-04-11 Zealand Pharmaceuticals A/S Novel use of peptide
CA2422916A1 (en) * 2000-09-26 2002-04-04 The University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
JP2002105067A (ja) 2000-09-28 2002-04-10 Teijin Ltd ２−フェニルチアゾール誘導体、およびそれを有効成分とする医薬組成物
US7057053B2 (en) * 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7524879B2 (en) * 2000-10-06 2009-04-28 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US6631745B2 (en) 2001-07-02 2003-10-14 Fmc Technologies, Inc. Riser pull-in method and apparatus
US6623729B2 (en) 2001-07-09 2003-09-23 Korea Advanced Institute Of Science And Technology Process for preparing sustained release micelle employing conjugate of anticancer drug and biodegradable polymer
JP2005501052A (ja) 2001-07-31 2005-01-13 イムノメディクス， インコーポレイテッド ポリマー送達系
JP2003113084A (ja) 2001-10-02 2003-04-18 Mitsubishi Pharma Corp 肺高血圧症の治療及び／または予防薬
IL147953A (en) 2002-02-01 2008-04-13 Meir Bialer Derivatives and pharmaceutical compositions of n-hydroxymethyl tetramethylcyclopropyl-
TW200407310A (en) 2002-06-07 2004-05-16 Glaxo Group Ltd Compounds
BR0312176A (pt) * 2002-06-21 2005-04-05 Suven Life Sciences Ltd Composto, composição farmaceutica, uso de um composto, método para o tratamento, método para reduzir a morbidez e a mortalidade associadas com o excesso de peso, processo para a preparação de um composto, novo intermediario e processo para a preparação de um novo intermediario
PL374781A1 (en) * 2002-06-28 2005-10-31 Idenix (Cayman) Limited 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
WO2004014973A2 (en) 2002-08-13 2004-02-19 Sirus Pharmaceuticals Ltd Biodegradable polymer
WO2004082585A2 (en) 2003-03-20 2004-09-30 Sirus Pharmaceuticals Ltd Water-soluble conjugates of phenytoin
WO2004098525A2 (en) 2003-05-02 2004-11-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
CA2524323C (en) 2003-05-02 2012-05-15 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
KR100495009B1 (ko) 2003-07-02 2005-06-14 삼성전자주식회사 화상형성 장치의 전사벨트 텐션 자동 인가 장치
WO2005018635A2 (en) 2003-08-07 2005-03-03 Cardiome Pharma Corp. Ion channel modulating activity i
WO2005079861A2 (en) * 2004-02-13 2005-09-01 Safeway Investments Ltd. Polymeric water soluble prodrugs
MXPA06011419A (es) * 2004-04-01 2007-04-20 Cardiome Pharma Corp Profarmacos de compuestos moduladores de canales ionicos y usos de los mismos.
WO2005097203A2 (en) 2004-04-01 2005-10-20 Cardiome Pharma Corp. Serum protein conjugates of ion channel modulating compounds and uses thereof
US7754897B2 (en) 2005-06-15 2010-07-13 Cardiome Pharma Corp. Synthetic processes for the preparation of aminocyclohexyl ether compounds
JP4991037B2 (ja) * 2004-04-01 2012-08-01 カーディオム ファーマ コーポレイション イオンチャネル調節化合物を含む薬物結合体
US7705036B2 (en) * 2004-04-01 2010-04-27 Cardiome Pharma Corp. Deuterated aminocyclohexyl ether compounds and processes for preparing same
US7845611B1 (en) * 2007-11-16 2010-12-07 Sholander Alfred M Door operated page turner device, system and method for books

Similar Documents

Publication Publication Date Title
JP2007531731A5 (https=)
JP7398391B2 (ja) Ｎ－［４－オキソ－２，３－ジヒドロ－１，５－ベンズオキサゼピン－３－イル］－５，６－ジヒドロ－４Ｈ－ピロロ［１，２－ｂ］ピラゾール－２－カルボキサミド誘導体及び例えば過敏性腸症候群（ＩＢＳ）を処置するためのＲＩＰ１キナーゼ阻害剤としての関連化合物
JP7759877B2 (ja) 治療用化合物
ES2620446T3 (es) Nuevo compuesto heterocíclico bicíclico
JP5387997B2 (ja) 血管の収縮または拡張による疾患治療剤
JP6760249B2 (ja) 三環性スピロ化合物
BR112019012688A2 (pt) método para produção de derivado de 7h-pirrol[2,3-d]pirimidina e intermediário sintético do mesmo
KR940007021A (ko) 흥분성 아미노산 수용체 길항물질
US10555951B2 (en) Targeted treatment of leiomyosarcoma
JP2007531766A5 (https=)
CN108366979B (zh) 与泛素化－蛋白酶体系统有关的化合物及医药组合物
JP2005531516A5 (https=)
JP2005504011A5 (https=)
JP2006504621A5 (https=)
JP2013529619A (ja) タンパク質キナーゼ阻害剤としてのヘテロアリール化合物および組成物
WO2014047393A1 (en) N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds as notch inhibitors
CN112638376B (zh) 取代的四氢环戊二烯并[c]吡咯、取代的二氢吡咯嗪、其类似物和其使用方法
WO2006043655A1 (ja) 吸入用医薬組成物
ES2609459T3 (es) Compuestos heterocíclicos condensados y su uso
JP6922712B2 (ja) 医薬用途
KR20230117574A (ko) 암 치료를 위한 metap2 억제제 및 cdk4/6 억제제의 조합
MX2024010403A (es) Derivado de imidazopiridazina, y método de preparación del mismo, composición farmacéutica del mismo y uso del mismo
CA3157778A1 (en) Substituted isoindolonyl 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same
TW201805267A (zh) 與泛素化-蛋白酶體系統有關之化合物及醫藥組合物
JP7713954B2 (ja) 核内受容体に対して活性な化合物